Arcus Biosciences, Inc. (RCUS)

22.82 -2.32 (-9.21%) USD  |  NYSE  |  Dec 12, 11:32
More

Arcus Biosciences Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for RCUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Actinium Pharmaceuticals, Inc. Upgrade
Apyx Medical Corp. Upgrade
Gilead Sciences, Inc. Upgrade
Merck & Co., Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade